Results 141 to 150 of about 4,098 (181)

Faculty Opinions recommendation of Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.

, 2018
Terry J. Smith
openalex   +2 more sources

A Pathway Analysis Based on Genome-Wide DNA Methylation of Chinese Patients with Graves’ Orbitopathy

, 2019
Xin Zhong, Lin Hua, Yi‐Lin Yang, Tingting Shi, Wei Liu, Xiu Tuo, Li Yu, Xi Cao, Fangyuan Yang   +8 more
openalex   +1 more source

Emergency Endoscopic Endonasal Optic Nerve Decompression for Graves' Orbitopathy. [PDF]

Cureus
Qassab O, Ouattassi N, Kamal D, Benmansour N, El Alami El Amine MN.   +4 more
europepmc   +1 more source

Role of Lysyl Oxidase-Like Protein 3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts. [PDF]

Invest Ophthalmol Vis Sci
Park SH, Choi SH, Park HY, Ko J, Yoon JS.   +4 more
europepmc   +1 more source

A combined transcriptomics and proteomics approach reveals S100A4 as a potential biomarker for Graves' orbitopathy. [PDF]

Front Genet
Chng CL, Lai OF, Seah LL, Yong KL, Chung YH, Goh R, Lim CK.   +6 more
europepmc   +1 more source

Subclinical Ocular Motility Dysfunction and Extraocular Muscle Changes in Inactive Graves' Orbitopathy. [PDF]

J Pers Med
Lixi F, Cuccu A, Giannaccare G, Onnis M, Timofte Zorila MM, Mariotti S, Vacca R, Meloni PE, Pisu M, Mura C, Boi F.   +10 more
europepmc   +1 more source

Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III). [PDF]

Br J Ophthalmol
Schuh A, Ayvaz G, Baldeschi L, Baretić M, Bechtold D, Boschi A, Brix TH, Burlacu MC, Ciric J, Covelli D, Currò N, Donati S, Eckstein AK, Fichter N, Führer D, Horn M, Jabłońska-Pawlak A, Juri Mandić J, Kahaly GJ, Konuk O, Langbein A, Lanzolla G, Marcocci C, Marinò M, Miśkiewicz P, Beleslin BN, Pérez-Lázaro A, Pérez-López M, Ponto KA, Quinn A, Rudofsky G, Salvi M, Schittkowski MP, Tanda ML, Toruner F, Vaidya B, Hintschich CR.   +36 more
europepmc   +1 more source

K-Means Clustering Reveals Long-Term Thyrotropin Receptor Antibody Patterns in Graves' Disease: Insights from a 10-Year Study with Implications for Graves' Orbitopathy. [PDF]

J Clin Med
Park J, Kim JH, Choi HY, Kim J, Kim SS, Yang SW.   +5 more
europepmc   +1 more source

Efficacy of Tocilizumab in Refractory Graves Orbitopathy From Real-World Clinical Practice: An Observational Study. [PDF]

J Endocr Soc
Wang M, Qin B, Liu C, Liu H, Li D.
europepmc   +1 more source

Quality of life in patients with Graves' orbitopathy submitted to orbital decompression: comparison between balanced and inferomedial techniques. [PDF]

Arq Bras Oftalmol
Leite CA, Pereira TS, Chiang J, Moritz RB, Gonçalves ACP, Monteiro MLR.   +5 more
europepmc   +1 more source